MAT's Q2 sales rise 10% as Vehicles and games gain, but higher costs and margin pressure drive a sharp earnings decline.
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
FormFactor (FORM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ZETA raises its 2026 outlook after Q2 as Athena adoption, AI-led revenue quality and partner selling strengthened growth and pipeline momentum.
Rockwell Automation reported its fiscal third-quarter 2026 results, with sales rising to US$2,313 million and net income to US$408 million, and raised its full-year 2026 sales and diluted EPS guidance. The company’s improved margins, stronger outlook, and growing software-led wins such as the Plex MES deployment at Arriyadh Roaster highlight how higher-value digital solutions are becoming a more important earnings driver. Next, we’ll examine how Rockwell’s stronger guidance and margin...
Palantir Technologies (PLTR) has just posted a 93% year over year revenue increase in its second quarter, supported by especially strong U.S. commercial demand and higher full year and third quarter guidance. See our latest analysis for Palantir Technologies. Palantir Technologies’ shares jumped 29.45% on a 1 day basis after the Q2 release and the 7 day share price return of 32.24% points to strong short term momentum, even though the year to date share price return is still down 3.10% and...
CEO Stephen Yalof tells WWD that the "resilient" consumer, the World Cup, domestic tourism and blockbuster movies fueled sales and traffic.
Best Buy (BBY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
KHC beats second-quarter earnings and sales estimates despite lower organic sales, while updating its 2026 EPS guidance.
LLY crushes Q2 earnings estimates and lifts its 2026 sales outlook as Mounjaro and Zepbound fuel strong revenue growth and newer drugs add momentum.
NI beats Q2 earnings and revenue estimates as NIPSCO gains offset weaker Columbia results, while data center growth and guidance remain in focus.
Innoviz Technologies (NASDAQ:INVZ) reported record second-quarter revenue of $18.1 million as higher recognition of non-recurring engineering, or NRE, revenue tied to customer milestones helped lift results. The lidar developer also said it is expanding into defense and homeland-security application
CLSK expects lower Q3 revenues and EPS as Bitcoin volatility, rising costs and network difficulty weigh on results.
Oshkosh tops Q2 estimates as sales rise 6.7% and Access orders hit $1.5B, but margin pressure and a slower fire truck ramp trim its 2026 outlook.
Carvana's Q2 revenues jump 52% on record retail volume and strong pricing, while EBITDA grows despite margin pressure from expansion investments.
Amgen beats Q2 earnings and revenue estimates and lifts its 2026 outlook. Key products witness strong growth despite biosimilar pressure on older drugs.
CleanSpark mined 586 BTC in July and ended the month with 13,931 BTC in inventory and a 50 EH/s operational hashrate
In this segment of the AI Investor Podcast from 24/7 Wall St., Eric Bleeker reviews Lam Research, a semiconductor equipment holding originally recommended to the million dollar AI portfolio he manages as part of a collection of memory-adjacent stocks. The quarter itself was solid: $1.82 in EPS against $1.70 expected, with the standout being guidance of $2.15 for next quarter versus a street estimate of $1.84. The stock jumped about 20% the next morning, though Bleeker attributes most of that to how far it had fallen during July's selloff rather than to the results, which he characterizes as good but not spectacular. His hesitation is valuation. Against a full-year estimate of $9.40, the shares trade a bit above 30 times forward earnings, which he considers the upper end of the historical range. He is not planning to add more with other opportunities across the market after a steep July sell-off. The broader read on semiconductor equipment is more bullish. Taiwan Semiconductor raised capex, Intel sounded optimistic on capex needs, and Bleeker guesses 2028 equipment spending could come in roughly 25% above where Wall Street currently models it. He is particularly interested in advanced packaging and testing, sub-verticals growing faster than the overall space. Lam remains a core long-term holding and, in his view, among the best operators in semi equipment.
Q's Q2 earnings jump 53% as AI-driven demand lifts sales 22%, fueling segment growth and a higher 2026 outlook.
DIS' fiscal Q3 earnings top estimates as Experiences and Entertainment drive profit growth, while streaming improves despite Sports headwinds.
Phillips 66's Q2 earnings surge on wider refining margins, while record midstream volumes and stronger chemicals results boost profits.
Lucid slams the brakes on cash burn -- but is it too late?
W beats Q2 estimates as stronger U.S. demand, market share gains and Perigold growth lift revenues and active customers.
Sunoco's Q2 2026 revenues and EBITDA rise y/y on acquisitions, higher fuel volumes and margins. SUN raises its 2026 guidance.
PSKY beats Q2 earnings and revenue estimates as DTC strength, a Studios turnaround and cost discipline offset TV Media weakness, with a solid Q3 outlook.
Digital Turbine tops Q1 fiscal 2027 earnings and revenue estimates, posts strong App Growth Platform gains and raises full-year revenue and EBITDA guidance.
SpaceX and Tesla CEO Elon Musk is famous for his sky-high ambitions, including reaching Mars one day. After SpaceX’s earnings report Tuesday, Musk laid out four more brazen goals for the rocket and artificial-intelligence company, including reaching $1 trillion in revenue in less than five years. SpaceX stock tumbled 8% to $115.29 on Wednesday, while the S&P 500 edged up 0.1%.
GILD beats Q2 revenue estimates as HIV sales fuel growth, while acquisition charges cause a loss. Higher HIV guidance and pipeline progress support momentum.
SVM heads into Q1 earnings with revenues expected to jump 70% despite lower silver output, as higher metal prices and gold sales may lift results.
EMR's Q3 earnings beat estimates as Software & Systems surged, margins expanded and strong cash flow supported a higher fiscal 2026 outlook.